In recent years, a growing number of clinical trials have used composite endpoints—multiple events all treated as one endpoint—as a way to boost the power of a study so that fewer participants are ...

-- Presented at the AAD VMX 2020, results from ECZTRA 1, 2 and 3 trials confirm tralokinumab met its primary and secondary endpoints and are the first Phase 3 results in atopic dermatitis for an ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Regulatory trials of chimeric antigen receptor T-cell therapies for autoimmune diseases could be ...

(RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) said the HELIOS-A phase 3 study of vutrisiran met all secondary endpoints measured at 18 months in patients with hATTR amyloidosis with polyneuropathy.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ocular itching and ocular redness decreased after ...